Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder affecting millions of individuals worldwide, posing significant challenges in accurate diagnosis and effective management [1]. ADHD impacts 3-10% of children, causing inattention, hyperactivity, and impulsivity that disrupt social, academic, and occupational life, potentially lasting into adulthood [2]. The complex symptomatology and heterogeneous nature of ADHD have long posed difficulties for healthcare professionals, leading to misdiagnosis, delayed management, and suboptimal outcomes. However, the rapid advancements in artificial intelligence (AI) offer a transformative opportunity to revolutionize the diagnosis and management of ADHD, providing a more objective, data-driven approach to improve patient outcomes. Enhancing diagnostic accuracy Traditional methods of diagnosis of ADHD in pediatric and adolescent individuals relies on a comprehensive approach encompassing a detailed clinical history, physical examination, review of information from home and community settings, and application of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria [3]. Reliance on subjective reports can be biased and miss co-existing conditions. The thorough evaluation process can be time-consuming and resource-heavy. Additionally, standardized assessments might not capture cultural nuances, potentially leading to misdiagnosis. These limitations pave the way for AI to potentially improve ADHD diagnosis, accuracy and efficiency [3]. As shown in Fig 1, AI's ability to process and analyze vast amounts of multimodal data, including neuroimaging, genetic, and behavioral information, has the potential to identify complex patterns and biomarkers associated with ADHD. Machine learning algorithms, such as support vector machines and deep neural networks, have shown promising results in classifying ADHD based on functional magnetic resonance imaging (fMRI) data, achieving high accuracy rates [4]. These AI-based approaches can detect subtle abnormalities in brain connectivity patterns that may be overlooked by human observers, providing objective evidence to support clinical decision-making. Moreover, AI can integrate multiple data sources, such as neuropsychological assessments, electronic health records, and even digital phenotyping data from wearable devices, to create comprehensive patient profiles and aid in the differential diagnosis of ADHD [5]. Recent studies have explored innovative AI-based approaches to enhance ADHD screening and diagnosis. For instance, Yoo et al. [2] developed a machine learning model using portable eye tracking data to assist in ADHD screening. The study demonstrated the potential of eye movement patterns as biomarkers for ADHD, with the AI model achieving promising